Mathematical modeling and analysis of ErbB3 and EGFR dimerization process for the gefitinib resistance

DOI10.14495/JSIAML.10.33zbMath1409.92104OpenAlexW2885994709MaRDI QIDQ3121410

Takashi Suzuki, Yoshinori Murakami, Keiko Itano, Takeshi Ito, Shu-Ji Kawasaki

Publication date: 18 March 2019

Published in: JSIAM Letters (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.14495/jsiaml.10.33

zbMATH Keywords

dimerizationgroupingEGFRErbB3gefitinib resistance

Mathematics Subject Classification ID

Kinetics in biochemical problems (pharmacokinetics, enzyme kinetics, etc.) (92C45) Physiology (general) (92C30)

Related Items (2)

A robust optimal control framework for controlling aberrant RTK signaling pathways in esophageal cancer ⋮ Mathematical modeling of the dimerization of EGFR and ErbB3 in lung adenocarcinoma

Cites Work

• Finding solvable units of variables in nonlinear ODEs of ECM degradation pathway network

This page was built for publication: Mathematical modeling and analysis of ErbB3 and EGFR dimerization process for the gefitinib resistance